On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
February 24, 2017
Wrong Site/Patient/Procedure Surgeries: Solutions for Prevention The Florida Board of Medicine has been holding meetings and conducting research on incidents of wrong site/person/procedure surgeries in Florida. While the overall number of incidents (when compared to the number of surgeries performed) … Continue reading
January 19, 2017
Please see updated information about the DEA’s suspension of McKesson Corporation and controlled substances Continue reading